In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 1, 1999, Pages 105-108

  Pradines, B ^a   Mabika Mamfoumbi, M M ^a   Parzy, D ^a   Owono Medang, M ^a   Lebeau, C ^a   Mourou Mbina, J R ^a   Doury, J C ^a   Kombila, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; CHLOROQUINE; HALOFANTRINE; PYRONARIDINE; QUININE;

ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG SENSITIVITY; GABON; IN VITRO STUDY; NONHUMAN; PLASMODIUM FALCIPARUM;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0032899902     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.105     Document Type: Article

References (36)

1. Wernsdorfer WH, 1991. The development and spread of drugresistant malaria. Parasitol Today 7: 297-303.
2. Barnes AJ, Ong EL, Dunbar EM, Mandal BK, Wilkins EGL, 1991. Failure of chloroquine and proguanil prophylaxis in travellers to Kenya. Lancet 338: 1338-1339.
3. Gay F, Binet MH, Bustos MDG, Rouveix B, Danis M, Roy C, Gentilini M, 1990. Mefloquine failure in child contracting falciparum malaria in West Africa. Lancet 335: 120-121.
4. Ringwald P, Bartczak S, Le Bras J, Bricaire F, Matheron S, Bauchet J, Coulaud JP, 1990. Failure of anti-malarial prophylaxis with mefloquine in Africa. Trans R Soc Trop Med Hyg 84: 348-349.
5. Basco LK, Le Bras J, Gillotin C, Ringwald P, Rabenjarson E, Gimenez F, Bouchaud O, Farinotti R, Coulaud JP, 1991. Type RI resistance to halofantrine in West Africa. Trop Med Parasitol 42: 413-414.
6. Jelinek T, Schelbert P, Loescher T, Eichenlaub D, 1995. Quinine resistant falciparum malaria acquired in East Africa. Trop Med Parasitol 46: 38-40.
7. Molinier S, Imbert P, Verrot D, Morillon M, Parzy D, Touze J E, 1994. Paludisme à Plasmodium falciparum: résistance de type RI à la quinine en Afrique de l''Est. Presse Med 23: 1484.
8. Zeng XY, Xia Y, Gao FH, Guo HZ & Chen C, 1979. Synthesis of 7351, a new antimalarial drug. Acta Pharmaceu Sin 14: 736-737.
9. Zeng XY, Chen C, Gao FH, Zhu PE, Guo HZ, 1982. Synthesis of new antimalarial drug pyronaridine and its analogues. Acta Pharmaceu Sin 17: 118-125.
10. Childs GE, Hausler B, Milhous W, Chen C, Wimonwattrawatee T, Pooyindee N, Boudreau EF, 1988. In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum. Am J Trop Med Hyg 38: 24-29.
11. Elueze EI, Croft SL, Warhurst DC, 1996. Activity of pyronaridine and mepacrine against twelve strains of Plasmodium falciparum in vitro. J Antimicrob Chemother 37: 511-518.
12. Shao BR, 1990. A review of antimalarial drug pyronaridine. Chinese Med J 103: 428-434.
13. Ringwald P, Bickii J, Basco LK, 1996. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347: 24-29.
14. Peters W, Robinson BL, 1992. The chemotherapy of rodent malaria. XLVII. Studies on pyronaridine and other Mannich base antimalarials. Ann Trop Med Parasitol 86: 455-465.
15. Kotecka BM, Barlin GB, Edstein MD, Rieckmann KH, 1997. New quinoline di-mannich base compounds with greater antimalarial activity than chloroquine, amodiaquine or pyronaridine. Antimicrob Agents Chemother 41: 1369-1374.
16. Warsame M, Wernsdorfer WH, Payne D, Bjorkman A, 1991. Positive relationship between response of Plasmodium falciparum to chloroquine and pyronaridine. Trans R Soc Trop Med Hyg 85: 570-571.
17. Basco LK, Le Bras J, 1992. In vitro activity of pyronaridine against African strains of Plasmodium falciparum. Ann Trop Med Parasitol 86: 447-454.
18. Schildbach S, Wernsdorfer WH, Suebsaeng L, Rooney W, 1990. In vitro sensitivity of multiresistant Plasmodium falciparum to new candidate antimalarial drugs in western Thailand. Southeast Asian J Trop Med Public Health 21: 29-38.
19. Kleinbaum DG, Kupper LL, Muller KE, 1987. The correlation coefficient and straight-line regression analysis. Payne M, ed. Applied Regression Analysis and Other Multivariable Methods. Second edition. Boston: PWS-Kent Publishing Company, 80-95.
20. Winkler S, Brandts C, Wernsdorfer WH, Graninger W, Bienzle U, Kremsner PG, 1994. Drug sensitivity of Plasmodium falciparum in Gabon. Activity correlations between various antimalarials. Trop Med Parasitol 45: 214-218.
21. Umontong AB, Ezedinechi EN, Okerengwo AA, Usanga EA, Udo JJ, Williams AI, 1991. Correlation between in vivo and in vitro response of chloroquine-resistant Plasmodium falciparum in Calabar, south-eastern Nigeria. Acta Trop 49: 119-125.
22. Pradines B, Tall A, Parzy D, Spiegel A, Fusai T, Hienne R, Trape JF, Doury JC, 1998. In vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs - Mannich bases: promising drugs for Africa? J Antimicrob Chemother 42: 333-339.
23. Yayon A, Cabantchik ZI, Ginsburg H, 1985. Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc Natl Acad Sci USA 82: 2784-2788.
24. Krogstad DJ, Schlesinger PH, Gluzman IY, 1985. Antimalarials increase vesicle pH in Plasmodium falciparum. J Cell Biol 101: 2302-2309.
25. Slater AFG, Cerami A, 1992. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355: 167-169.
26. Dorn A, Stoffel R, Matile H, Bubendorf A, Ridley RG, 1995. Malarial haemozoin/β-haematin supports haem polymerization in the absence of protein. Nature 374: 269-271.
27. Krogstad DJ, Gluzman IY, Kyle DE, Oduola AMJ, Martin SK, Milhous WK, Schlesinger PH, 1987. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238: 1283-1285.
28. Cowman AF, Karzc S, Galatis D, Culvenor JG, 1991. A P-glycoprotein homologue of Plasmodium falciparum is isolated on the digestive vacuole. J Cell Biol 113: 1033-1045.
29. Walliker D, 1994. The role of molecular genetics in field studies on malaria parasites. Int J Parasitol 24: 799-808.
30. Su X, Kirkman LA, Fujioka H, Wellems TE, 1997. Complex polymorphisms in a approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91: 593-603.
31. Wu LJ, Rabbege JR, Nagasawa H, Jacobs G, Aikawa M, 1988. Morphological effects of pyronaridine on malaria parasites. Am J Trop Med Hyg 38: 30-36.
32. Dorn A, Vippagunta SR, Matile H, Jaquet C, Vennerstrom JL, Ridley RG, 1998. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerization by quinoline antimalarials. Biochem Pharmacol 55: 727-736.
33. Nateghpour M, Ward SA, Howells RE, 1993. Development of halofantrine resistance and determination of cross-resistance patterns in Plasmodium falciparum. Antimicrob Agents Chemother 37: 2337-2343.
34. Ritchie GY, Mungthin M, Green JE, Bray PG, Hawley SR, Ward SA, 1996. In vitro selection of halofantrine resistance in Plasmodium falciparum is not associated with increased expression of Pgh 1. Mol Biochem Parasitai 83: 35-46.
35. Chang C, Lin-Hua T, Jantanavivat C, 1992. Studies on a new antimalarial compound: pyronaridine. Trans R Soc Trop Med Hyg 86: 7-10.
36. Peters W, Robinson BL, 1997. The chemotherapy of rodent malaria. LV. Interactions between pyronaridine and artemisinin. Ann Trop Med Parasitol 91: 141-145.